Acurx Pharmaceuticals ACXP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 3.71 | -0.62 | -1,716 | -2 | ||
| 2025Q4 | 2.49 | 102.47 | -0.31 | -1,617 | -2 | |
| 2025Q3 | 4.29 | 101.81 | -1 | -2,029 | -2 | |
| 2025Q2 | 10.22 | 102.27 | -1.81 | -2,297 | -2 | |
| 2025Q1 | 7.8 | -2.2 | -2,149 | -2 | ||
| 2024Q4 | 16.28 | 99.71 | -3.22 | -2,774 | -3 | |
| 2024Q3 | 38 | 99.89 | -3.39 | -2,818 | -3 | |
| 2024Q2 | 45 | -5.24 | -4,122 | -4 | ||
| 2024Q1 | 49 | -5.6 | -4,378 | -4 | ||
| 2023Q4 | 76.6 | -7.6 | -5,115 | -5 | ||
| 2023Q3 | 30 | -4.8 | -3,115 | -3 | ||
| 2023Q2 | 53 | -5.6 | -3,445 | -3 | ||
| 2023Q1 | 69.2 | -5 | -2,903 | -3 | ||
| 2022Q4 | 79.6 | -5.6 | -3,261 | -3 | ||
| 2022Q3 | 60 | -6.4 | -3,542 | -4 | ||
| 2022Q2 | 75.8 | -5.2 | -2,621 | -3 | ||
| 2022Q1 | 65.6 | -5.2 | -2,670 | -3 | ||
| 2021Q4 | 86.43 | -4.4 | -2,627 | -3 | ||
| 2021Q3 | 102.8 | -9.6 | -4,642 | -5 | ||
| 2021Q2 | 127.6 | 101.67 | -11.6 | -4,071 | -4 |